Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Contact Us
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Sports
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Advanced Manufacturing and Industrials
    • Art and Cultural Property
    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Entertainment & Sports
    • Financial Institutions
    • Healthcare
    • Higher Education
    • Infrastructure
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Articles
    4. California AG’s amicus brief backs scrutiny of PC-MSO models

      Articles

    Article

    California AG’s amicus brief backs scrutiny of PC-MSO models

    April 27, 2026

    LinkedInX (Twitter)EmailCopy URL

    PC-MSO enterprises in California should monitor evolving CPOM enforcement signals and consider reviewing their agreements for compliance.

    Authors

    • Harsh P. Parikh

      Partner
      • Los Angeles +1 213.629.6108
      • San Francisco +1 415.984.5024
      • hparikh@nixonpeabody.com
      Harsh P. Parikh
    • Alexandra Busto

      Partner
      • Los Angeles +1 213.629.6146
      • abusto@nixonpeabody.com
      Alexandra Busto
    • Patrick Callaghan

      Counsel
      • Los Angeles +1 213.629.6088
      • pcallaghan@nixonpeabody.com
      Patrick Callaghan

    The California Attorney General (AG) filed an unsolicited amicus brief in Art Center Holdings, Inc., et al. v. WCE CA ART, LLC, et al., arguing that professional corporation–management services organization (PC–MSO) arrangements in which the management services organization (MSO) maintains rights to replace the physician-owner violate California’s prohibition on the corporate practice of medicine (CPOM), even if the MSO never exercises those rights. The filing is worth monitoring for California PC-MSO models that rely on continuity agreements, assignable option agreements, stock transfer agreements, or similar arrangements that grant the MSO certain contractual controls to replace physician owners.

    In this alert, our California healthcare lawyers explain California’s CPOM framework, analyze the AG’s arguments and their intersection with existing state regulations governing investor influence in healthcare, and outline practical strategies for addressing compliance.

    CPOM interpretation at the center of initial dispute and amicus brief

    The underlying dispute arises from WCE, a private equity-backed MSO that provided management services to a physician-owned professional corporation. The trial court granted a receivership to restore control to the physicians, finding that WCE’s Continuity Agreement, which permitted the MSO to terminate the physician-owner and transfer PC equity to an MSO-chosen successor physician, constituted an unlicensed CPOM. The Court of Appeal case is now pending, with the AG appearing as amicus curiae in support of neither part but endorsing the trial court’s CPOM analysis.

    The brief argues that agreements that give nonprofessional corporations the right to replace a PC’s physician-owner effectively grant the corporation control over physician employment and, indirectly, over all aspects of the practice, violating CPOM regardless of whether the replacement right is exercised. Separately, SB 351, signed into law in October 2025, independently codifies longstanding CPOM parameters with specific application to private equity and hedge funds, prohibiting interference with clinical judgment and control over reserved professional functions. SB 351 declares offending contract terms void and unenforceable and authorizes the AG to seek injunctive relief with fee recovery, signaling a meaningful escalation in enforcement prioritization and capacity.

    The AG’s brief situates its CPOM analysis within SB 351’s framework, underscoring that private equity- and hedge-fund-backed MSO strategies that control physician employment or clinical functions are squarely within the new statute’s crosshairs.

    California’s CPOM prohibition and its purposes

    California’s Medical Practice Act prohibits unlicensed persons from practicing medicine and prohibits employing, aiding, or abetting any unlicensed person to do so, forming the basis of the CPOM ban. Courts and the AG have long read this framework to bar nonprofessional corporations from providing or controlling the provision of medical care, except for narrow statutory exemptions, such as certain HMOs and nonprofit community clinics. The policy rationale centers on preventing the commercial exploitation of the physician–patient relationship and the “middleman” profit motive, which can distort clinical judgment through divided loyalties.

    California case law and Medical Board guidance on CPOM liability looks at the substance of arrangements, scrutinizing direct exercise and retention of control over medical practice decisions, both contractually and in practice. The Medical Board has historically identified certain decisions affecting a medical practice as nondelegable to unlicensed persons, including MSOs, because they are viewed as clinical decisions that must be reserved for licensed physicians. These include coding and billing affecting care, approving equipment selections, and selecting or firing physicians based on clinical competency.

    The PC–MSO model: Permissible administrative support versus impermissible control

    The AG acknowledges that nonphysicians may legitimately provide certain administrative and operational support to physician practices, often through MSOs, provided these functions do not confer control over the practice of medicine. In addition to a management services arrangement, common contractual mechanisms in a PC-MSO arrangement include continuity agreements, assignable options, and stock transfer agreements that typically prohibit physician equity transfers without MSO approval, allow the MSO to terminate the management agreement unilaterally, and automatically transfer the PC equity to an MSO-chosen physician upon termination.

    The AG’s amicus position in Art Center Holdings

    The AG’s amicus filing supports the trial court’s CPOM analysis, arguing that agreements permitting a nonprofessional corporation to replace the physician-owner of a PC violate California law. The brief frames the issue as both control over physician hiring and firing and a broader assertion of indirect control over all aspects of the practice by virtue of potential leverage over the physician-owner.

    The AG’s brief explains that when MSOs extend beyond permissible administrative and operational services and assume increasing control over practice governance and decision-making, CPOM is violated. The risk of this impermissible scope creep may arise when an MSO installs a nominal physician-owner of a PC who is subject to contractual controls that allow the MSO to decide who owns or leads the PC’s clinical operations, which the AG views as indistinguishable from lay control and ownership of the medical practice, arguing that even general “comply with law” savings clauses do not cure these provisions because California contract interpretation prioritizes specific replacement and transfer rights over general language.

    Importantly, the AG contends that the violation does not depend on the actual exercise of the replacement right; the mere retention of the right creates an impermissible division of loyalties because physicians may tailor decisions to the MSO’s preferences to avoid replacement, thereby undermining patient-centered judgment.

    Risk stratification and areas of nuance

    In light of the amicus brief and SB 351, risk is heightened for PE-based MSO arrangements in which nonprofessional corporations hold contractual control over physician ownership, hiring, firing, or over functions the Medical Board treats as nondelegable. The AG notes that not all MSO–PC relationships are per se unlawful; absent the offending contractual terms, analysis turns on the totality of the circumstances.

    Notably, the brief does not analyze or extend any categorical safe harbor to arrangements that emulate captive PC control features in a clinical context, such as the “medical foundation” model. Where nonprofit health systems operate or align with outpatient practices through friendly PC models, risk likely depends on compliance with governance standards that reserve all clinical functions and physician employment decisions based on competency to licensed professionals.

    Calibration strategies aligned to the AG’s view

    Importantly, at this time, the AG’s amicus brief represents one interpretation of the law and has not been adopted by any court. This may ultimately prove to be a political signal rather than an immediate change in legal standards. Nonetheless, it is prudent to anticipate enforcement and potential changes to the law, particularly given the AG’s enforcement capabilities under SB 351. For example, agreements may be modified to eliminate MSO-held rights to replace physician-owners. More conservative approaches include: (1) limiting replacement triggers to true “for cause” scenarios; (2) requiring successor physicians to be selected by the PC’s board rather than designated by the MSO; and (3) structuring the control agreement solely between the PC and the physician-shareholder.

    Consistent with long-standing CPOM parameters, governance documents and management services agreements should clearly and demonstrably reserve all clinical decision-making, coding and billing that affects patient care, clinical equipment approvals, and physician selection, hiring, and firing based on competency to licensed physicians.

    Key takeaways

    The AG’s brief addresses “friendly PC” models and investor control in the traditional MSO/PE context, but does not analyze clinical models in California healthcare that utilize this structure, which contain more nuance.

    We do not expect the court’s decision in Art Center Holdings to address the AG’s broader arguments, which go beyond the specific issues in the case. However, if these arguments gain traction, or if a sale or other transaction is contemplated (particularly where OHCA review and oversight is triggered for PE-backed enterprises), it may be helpful to proactively review and update relevant agreements. Organizations should inventory their PC–MSO agreements for provisions that enable (or appear to do so) nonprofessional control over physician employment or ownership succession, and assess whether any delegations of clinical functions exist.

    Where revisions are warranted, parties should prioritize restructuring replacement-and- succession provisions. Governance documents should clearly reserve all clinical functions and physician employment decisions to licensed professionals. As always, entities should ensure that the operational distinctions between clinical authority and business services are not only documented but actively maintained in practice.

    Practices

    HealthcareHealthcare FinanceHealthcare TransactionsHealthcare Regulatory & Compliance

    Industries

    Healthcare

    Insights And Happenings

    • Alert

      New Jersey issues modified guidance on Schedule II CDS prescribing requirements

      March 9, 2026
    • Alert

      New York State OMIG releases 2026 Work Plan

      March 6, 2026
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Contact Us
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Supplier Code of Conduct
    • Nixon Peabody International LLP
    • PAL
    © 2026 Nixon Peabody. All rights reserved